Arrowhead Pharmaceuticals Corp (ARWR)

27.50 -0.62 (2.20%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/19 *Est.)

Latest Headlines

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) June 21, 2019 6:45 PM - BizWire Arrowhead Pharmaceuticals (ARWR) Confirms it Received Orphan Drug Designation for ARO-APOC3 June 21, 2019 7:31 AM - StreetInsider Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-APOC3 June 21, 2019 7:30 AM - BizWire Arrowhead Pharmaceuticals (ARWR) Treatment of Familial Chylomicronemia Syndrome Granted FDA Orphan Status June 20, 2019 4:04 PM - StreetInsider Form SC 13G/A ARROWHEAD PHARMACEUTICAL Filed by: BlackRock Inc. June 7, 2019 5:01 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: May 31 Filed by: Myszkowski Kenneth Allen June 3, 2019 6:13 PM - SEC Filing Arrowhead Pharmaceuticals to Present at Upcoming June 2019 Conferences May 31, 2019 4:00 PM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: May 28 Filed by: O'Brien Patrick May 29, 2019 7:02 PM - SEC Filing Form 4 ARROWHEAD PHARMACEUTICAL For: May 24 Filed by: Anzalone Christopher Richard May 29, 2019 6:58 PM - SEC Filing Arrowhead Research (ARWR) PT Raised to $32 at B.Riley/FBR May 28, 2019 3:43 AM - StreetInsider Form 4 ARROWHEAD PHARMACEUTICAL For: May 21 Filed by: Myszkowski Kenneth Allen May 22, 2019 5:45 PM - SEC Filing Kontoor Brands and Arrowhead Pharmaceuticals Set to Join S&P SmallCap 600 May 20, 2019 5:56 PM - PR NewsWire After-Hours Movers 05/20: (ARWR) (CLVS) (ASNA) Higher; (OCUL) (QTT) (INSM) (more...) May 20, 2019 5:48 PM - StreetInsider Arrowhead Pharmaceuticals Corp (ARWR) Climbs 6.6% on News it Will Join S&P SmallCap 600 May 20, 2019 5:25 PM - StreetInsider Kontoor Brands (KTB) and Arrowhead Pharmaceuticals (ARWR) Set to Join S&P SmallCap 600 May 20, 2019 5:22 PM - StreetInsider Form 10-Q ARROWHEAD PHARMACEUTICAL For: Mar 31 May 8, 2019 4:14 PM - SEC Filing Form 8-K ARROWHEAD PHARMACEUTICAL For: May 08 May 8, 2019 4:08 PM - SEC Filing Arrowhead Pharmaceuticals Corp (ARWR) Tops Q2 EPS by 5c May 8, 2019 4:01 PM - StreetInsider Arrowhead Pharmaceuticals Reports Fiscal 2019 Second Quarter Results May 8, 2019 4:00 PM - BizWire Arrowhead Pharmaceuticals to Present at Upcoming May 2019 Conferences May 2, 2019 7:30 AM - BizWire Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Second Quarter Results April 24, 2019 4:00 PM - BizWire Arrowhead Pharmaceuticals Corp (ARWR) Commences Triple Combination Cohort in Chronic HBV Patients; Reports $25M Milestone Payment from Janssen April 24, 2019 7:39 AM - StreetInsider Arrowhead Begins Triple Combination Cohort in Chronic HBV Patients and Earns $25 Million Milestone Payment from Janssen April 24, 2019 7:30 AM - BizWire Form 8-K ARROWHEAD PHARMACEUTICAL For: Apr 17 April 19, 2019 5:11 PM - SEC Filing UPDATE: Arrowhead Research (ARWR) PT Raised to $33 at Piper Jaffray April 15, 2019 4:58 PM - StreetInsider Arrowhead Pharma (ARWR) Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15, 2019 7:36 AM - StreetInsider Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15, 2019 7:30 AM - BizWire Arrowhead (ARWR) Presents Clinical Data on JNJ-3989 (ARO-HBV) at EASL April 12, 2019 12:46 PM - StreetInsider Arrowhead Presents Clinical Data on JNJ-3989 (ARO-HBV) at The International Liver Congress™ April 12, 2019 12:45 PM - BizWire Arrowhead Preclinical Data Demonstrates RNAi Therapy Prevents and Reverses Alpha-1 Liver Disease at The International Liver Congress™ April 12, 2019 6:00 AM - BizWire Form 4 ARROWHEAD PHARMACEUTICAL For: Apr 03 Filed by: Anzalone Christopher Richard April 5, 2019 6:58 PM - SEC Filing Form S-8 ARROWHEAD PHARMACEUTICAL March 29, 2019 4:57 PM - SEC Filing Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29, 2019 4:30 PM - BizWire Full Article List